PMID- 33251635 OWN - NLM STAT- MEDLINE DCOM- 20210917 LR - 20210917 IS - 1521-4095 (Electronic) IS - 0935-9648 (Linking) VI - 33 IP - 2 DP - 2021 Jan TI - Tailored Mesoporous Inorganic Biomaterials: Assembly, Functionalization, and Drug Delivery Engineering. PG - e2005215 LID - 10.1002/adma.202005215 [doi] AB - Infectious or immune diseases have caused serious threat to human health due to their complexity and specificity, and emerging drug delivery systems (DDSs) have evolved into the most promising therapeutic strategy for drug-targeted therapy. Various mesoporous biomaterials are exploited and applied as efficient nanocarriers to loading drugs by virtue of their large surface area, high porosity, and prominent biocompatibility. Nanosized mesoporous nanocarriers show great potential in biomedical research, and it has become the research hotspot in the interdisciplinary field. Herein, recent progress and assembly mechanisms on mesoporous inorganic biomaterials (e.g., silica, carbon, metal oxide) are summarized systematically, and typical functionalization methods (i.e., hybridization, polymerization, and doping) for nanocarriers are also discussed in depth. Particularly, structure-activity relationship and the effect of physicochemical parameters of mesoporous biomaterials, including morphologies (e.g., hollow, core-shell), pore textures (e.g., pore size, pore volume), and surface features (e.g., roughness and hydrophilic/hydrophobic) in DDS application are overviewed and elucidated in detail. As one of the important development directions, advanced stimuli-responsive DDSs (e.g., pH, temperature, redox, ultrasound, light, magnetic field) are highlighted. Finally, the prospect of mesoporous biomaterials in disease therapeutics is stated, and it will open a new spring for the development of mesoporous nanocarriers. CI - (c) 2020 Wiley-VCH GmbH. FAU - Zou, Yidong AU - Zou Y AUID- ORCID: 0000-0002-3549-8430 AD - Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. FAU - Huang, Biaotong AU - Huang B AD - Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. FAU - Cao, Liehu AU - Cao L AD - Department of Orthopedics, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, China. AD - Department of Orthopedics Trauma, Shanghai Luodian Hospital, Baoshan District, Shanghai, 201908, China. FAU - Deng, Yonghui AU - Deng Y AUID- ORCID: 0000-0002-0657-9397 AD - Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers, Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, 200433, China. AD - State Key Lab of Transducer Technology, Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, China. FAU - Su, Jiacan AU - Su J AD - Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. AD - Department of Orthopedics, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, 200433, China. LA - eng GR - 91749204/NSF of China/ GR - 81771491/NSF of China/ GR - 21673048/NSF of China/ GR - 21875044/NSF of China/ GR - 2018YFA0209401/National Key Research and Development Program of China/ GR - 20JC1415300/Science and Technology Commission of Shanghai Municipality/ GR - 19XD1420300/Program of Shanghai Academic Research Leader/ GR - SKT1904/state key laboratory of Transducer Technology of China/ GR - Youth Top-notch Talent Support Program of China/ PT - Journal Article PT - Review DEP - 20201130 PL - Germany TA - Adv Mater JT - Advanced materials (Deerfield Beach, Fla.) JID - 9885358 RN - 0 (Biocompatible Materials) RN - 0 (Drug Carriers) RN - 0 (Inorganic Chemicals) SB - IM MH - Biocompatible Materials/*chemistry MH - Drug Carriers/*chemistry MH - *Engineering MH - Inorganic Chemicals/*chemistry MH - Porosity OTO - NOTNLM OT - disease therapy OT - drug delivery OT - mesoporous nanocarriers OT - stimuli-responsive system EDAT- 2020/12/01 06:00 MHDA- 2021/09/18 06:00 CRDT- 2020/11/30 05:57 PHST- 2020/07/31 00:00 [received] PHST- 2020/08/18 00:00 [revised] PHST- 2020/12/01 06:00 [pubmed] PHST- 2021/09/18 06:00 [medline] PHST- 2020/11/30 05:57 [entrez] AID - 10.1002/adma.202005215 [doi] PST - ppublish SO - Adv Mater. 2021 Jan;33(2):e2005215. doi: 10.1002/adma.202005215. Epub 2020 Nov 30.